Bui Thi Kim Ly

Suggest Changes
Learn More
BACKGROUND Imatinib, a selective tyrosine kinase inhibitor, has been used as a standard first-line therapy for irresectable and metastasized gastrointestinal stromal tumor (GIST) patients.(More)
  • 1